Be Clinical has raised $2.2M in seed funding, a bet on the growing demand for clinical-grade skincare in India. The round’s backers weren’t disclosed, but the capital gives the young brand room to build out its product pipeline and market presence.
The company is positioning itself as a science-first alternative in a crowded beauty space, offering anti-ageing formulas designed for Indian skin and climate. With a focus on results over hype, Be Clinical aims to tap into a consumer base that’s increasingly skeptical of generic creams and hungry for dermatologist-backed solutions. The seed round signals early investor confidence in that niche, even as the competitive landscape heats up.
